Role of linezolid combination therapy for serious infections: review of the current evidence

H Chen, Y Du, Q Xia, Y Li, S Song, X Huang - European Journal of Clinical …, 2020 - Springer
As long-standing clinical problems, a series of complicated infections are more difficult to
treat due to the development of antibiotic resistance, especially caused by methicillin …

[HTML][HTML] Potential strategies for the management of drug-resistant tuberculosis

D Sharma, S Sharma, J Sharma - Journal of Global Antimicrobial …, 2020 - Elsevier
In the current scenario, the emergence of drug resistance in Mycobacterium tuberculosis is
the consequence of the failure of conventional diagnostic and treatment approaches. To …

Bedaquiline for the Treatment of Multidrug-resistant Tuberculosis in the United States

S Mase, T Chorba, S Parks, A Belanger… - Clinical Infectious …, 2020 - academic.oup.com
Abstract Background In 2012, the Food and Drug Administration approved use of
bedaquiline fumarate as part of combination therapy for multidrug-resistant tuberculosis …

Telemedicine technologies and tuberculosis management: a randomized controlled trial

P Guo, W Qiao, Y Sun, F Liu, C Wang - Telemedicine and e-Health, 2020 - liebertpub.com
Background: Since 1990s, directly observed therapy (DOT) has been the standard-of-care
for tuberculosis (TB), although it is cumbersome for patients as well as service providers. For …

Outcomes and adverse events of pre-and extensively drug-resistant tuberculosis patients in Kinshasa, Democratique Republic of the Congo: A retrospective cohort …

IM Kashongwe, F Mawete, L Mbulula, DJ Nsuela… - PloS one, 2020 - journals.plos.org
Background Extensively drug-resistant tuberculosis (XDR TB) is a very serious form of
tuberculosis that is burdened with a heavy mortality toll, especially before the advent of new …

[HTML][HTML] Improving quality of patient data for treatment of multidrug-or rifampin-resistant tuberculosis

JR Campbell, D Falzon, F Mirzayev… - Emerging Infectious …, 2020 - ncbi.nlm.nih.gov
International policy for treatment of multidrug-and rifampin-resistant tuberculosis (MDR/RR
TB) relies largely on individual patient data (IPD) from observational studies of patients …

[PDF][PDF] Custo-utilidade do uso de esquemas encurtados para tratamento da tuberculose multidroga resistente

AS Portela - 2020 - repositorio-bc.unirio.br
Introdução: Diante das perspectivas mundial e brasileira da crescente incidência de TB-
MDR, tornam-se necessários estudos de incorporação de novos esquemas terapêuticos …

Avaliação da evolução clínica de pacientes portadores de Tuberculose Resistente a Múltiplos Medicamentos

PS da Silva Rocha, DNR de Carvalho… - Research, Society and …, 2020 - rsdjournal.org
Objective: To assess the clinical evolution of patients with Multiple Drug-Resistant
Tuberculosis treated in a referral center in the Amazon region, between the years 2010 to …

Pretomanid Sebagai Obat Anti-Tuberkulosis: Sebuah Studi Kajian Sistematis

R Rasiha - 2020 - repository.unhas.ac.id
Latar Belakang: Sekitar 10 juta penduduk di seluruh dunia menderita penyakit tuberkulosis
(TB) dan dan 1, 5 juta di antaranya meninggal akibat penyakit tersebut. Regimen oral …

The Study of Human Tuberculosis Lesions: circulant and transcriptional biomarkers in a cohort of tuberculosis patients undergoing therapeutic surgery

A Despuig - 2020 - ddd.uab.cat
La tuberculosi (TB), és la major causant de morts associades a malalties infeccioses al món.
La cirurgia terapèutica segueix sent una eina essencial en els casos més complicats de TB …